Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5813 posts found.

Sanofi and Blackstone Life Science collaborate to advance multiple myeloma treatment

March 15, 2022 Manufacturing and Production

Sanofi and Blackstone announced a strategic, risk-sharing €300 million collaboration, to advance innovative treatment for multiple myeloma. This funding will …
News

Grifols XEMBIFY receives European approvals

March 15, 2022 Manufacturing and Production

Grifols has announced that XEMBIFY, its innovative 20% subcutaneous immunoglobulin (SCIG), has been approved by several European Union member state …
News

Groundbreaking comprehensive genomic profiling test for cancer

March 15, 2022 Manufacturing and Production

Illumia have announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumour genes and …
News

Almirall announces collaboration with University of Michigan

March 15, 2022 Manufacturing and Production

Almirall has announced a collaboration agreement with the University of Michigan to accelerate the understanding of the factors that trigger …
News

Study may see end of need for invasive endometriosis diagnosis surgery

March 8, 2022 Manufacturing and Production

A new study of women living with endometriosis is underway, exploring the potential of Artificial intelligence (AI), and cutting-edge medical …
News

Neuraxpharm expands in Southeast Europe

March 8, 2022 Manufacturing and Production

Neuraxpharm Group have announced the expansion of its business in Southeast Europe, through the acquisition of Brain Therapeutics, a company …
News

Major US study finds COVID-19 vaccines not linked to deaths

March 8, 2022 Manufacturing and Production

A study into vaccine side-effects, based in the US, has found no link between two COVID-19 jabs and the number …
News

Moderna faces lawsuit over COVID-19 vaccine

March 1, 2022 Manufacturing and Production

Moderna has been accused of ‘hijacking’ technology from two smaller biotech firms – Arbutus Biopharma and Genevant Sciences – to …
News

ELUNATE receives commercial approval in Macau

March 1, 2022 Manufacturing and Production

HUTCHMED has received approval to market fruquintinib (ELUNATE in China), a selective and potent oral inhibitor of vascular endothelial growth …
News

FDA approves CAR-T therapy for multiple myeloma

March 1, 2022 Manufacturing and Production

The FDA gas approved a therapy developed by J&J and its partner Legend Biotech, to treat relapsed or refractory multiple …
News

First oral diabetes treatment approved in Europe for use during pregnancy

March 1, 2022 Manufacturing and Production

Merck has announced an extension to the label for metformin products in the EU – glucophage (metformin hydrochloride immediate release), …
News

FDA grants approval for expanded indication of heart failure sensor

February 22, 2022 Manufacturing and Production

The FDA has granted approval for an expanded indication of Abbott’s CardioMEMS HF System, a small implantable sensor that can …
News

NovoBiome and Inserm begin collaboration into human intestinal physiology

February 22, 2022 Manufacturing and Production

NovoBiome, a drug discovery company developing breakthrough Live Biotherapeutics Products, announced that it has signed a new collaboration with the …
News

UK to offer extra COVID-19 booster for over-75s and high risk in spring

February 22, 2022 Manufacturing and Production

An additional booster dose will be offered to all adults over-75, as well as the most vulnerable over-12s, in the …
News

Apollo Therapeutics and King’s College London collaborate for translational biology and drug development

February 22, 2022 Manufacturing and Production

Apollo Therapeutics has expanded its partnerships with world-leading UK research institutions, entering into a strategic collaboration with King’s College, London. …
News

Latest content

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024

AskBio initiates phase 2 Parkinson’s trial recruitment

June 26, 2024

AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment

June 25, 2024